Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
Cryoport, Inc., a Nevada corporation, filed this Current Report on Form 8-K on February 4, 2011. The filing details the entry into a material definitive agreement and the completion of the first close of a private placement of securities.
Key Financial Metrics and Transaction Details
- Gross Proceeds: $4,434,722
- Net Proceeds: Approximately $3,852,000 (after estimated cash offering expenses)
- Securities Issued: 6,335,318 Units
- Price per Unit: $0.70
- Unit Composition: One share of Common Stock and one warrant to purchase one share of Common Stock.
- Warrant Terms: Exercise price of $0.77 per share; immediately exercisable; five-year term.
- Placement Agent Fees: Emergent Financial Group, Inc. received a 10% commission, a 3% non-accountable finance fee, and a warrant to purchase 1,267,064 shares at $0.77 per share.
Material Changes and Use of Proceeds
The company intends to use the net proceeds from this transaction for working capital purposes. The filing notes that a second close of the private placement may occur within the next several weeks. The filing does not provide comparative financial metrics such as revenue, profit, or cash flow for the period, as this is a transaction-specific report rather than a periodic financial statement.
Outlook, Obligations, and Risks
- Registration Rights: Cryoport is obligated to file a registration statement with the SEC within 90 days following the close of the transaction to register the resale of the Common Stock and underlying warrant shares.
- Penalties: The Registration Rights Agreement provides for certain payments by the Registrant to Investors if the registration statement is not filed within the required period.
- Compliance: The sale was conducted under exemptions provided by Rule 505 and/or Rule 506 of Regulation D and/or Section 4(2) of the Securities Act of 1933.
Key Facts for Investor Verification
- Verify the total number of Units issued and the final net proceeds after all offering expenses are accounted for.
- Confirm the timeline for the anticipated second close of the private placement.
- Monitor the filing of the required registration statement within the 90-day window to avoid penalty payments.
- Review the full text of the Purchase Agreement and Registration Rights Agreement, which are filed as exhibits to the Form 10-K for the fiscal year ended March 31, 2011.